A study analysing factors associated with Sustained virological response (SVR) rates for the treatment of chronic hepatitis C virus (HCV)–infected patients
Latest Information Update: 31 Jul 2024
At a glance
- Drugs Ombitasvir/paritaprevir/ritonavir (Primary) ; Asunaprevir/daclatasvir; Ledipasvir/sofosbuvir
- Indications Hepatitis C
- Focus Therapeutic Use
Most Recent Events
- 31 Jul 2024 Status changed from not stated to completed.
- 15 Jun 2019 New trial record